• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT OMNILINK ELITE PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT OMNILINK ELITE PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 1012622-19
Device Problems Off-Label Use (1494); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hypersensitivity/Allergic reaction (1907); Rash (2033)
Event Date 08/14/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Estimated date.The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the case information, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effect of allergic reaction is listed in the otw omnilink elite instructions for use as a known potential complication associated with the use of the device.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
It was reported that the procedure was performed on (b)(6) 2018 to treat a lesion in the superior mesenteric artery.A 6.0mmx19mmx80cm omni elite stent was implanted without issue.The patient was started on plavix on (b)(6) 2018.Two or three weeks after the procedure (date unknown), the patient developed a rash, itching and hives throughout the body.The patient saw her primary doctor and the patient was given prednisone and hydroxyzine.The physician informed the patient the reaction she is having does not appear to be related to an antibiotic she is taking for dental treatment performed after the stent implant procedure.The patient was taking the antibiotic from (b)(6) to (b)(6).The patient will see an allergist and dermatologist this week.No additional information was provided.
 
Manufacturer Narrative
(b)(4).It was reported that the procedure was performed to treat a lesion in the superior mesenteric artery.The instructions for use states: the omnilink elite stent system is indicated for the treatment of atherosclerotic iliac artery lesions.Although the device was used off-label, there does not appear to be any relation to the reported patient effects.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNILINK ELITE PERIPHERAL STENT SYSTEM
Type of Device
PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
CLONMEL, IRELAND REG# 9616693
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key7882803
MDR Text Key120472749
Report Number2024168-2018-07219
Device Sequence Number1
Product Code NIO
UDI-Device Identifier08717648179181
UDI-Public08717648179181
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Reporter Occupation Non-Healthcare Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 09/25/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2020
Device Catalogue Number1012622-19
Device Lot Number7011841
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/11/2018
Initial Date FDA Received09/17/2018
Supplement Dates Manufacturer Received09/19/2018
Supplement Dates FDA Received09/25/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/01/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age82 YR
Patient Weight73
-
-